Shares of AnaptysBio, Inc. (NASDAQ:ANAB) opened at $65.33, and ended -3.17% lower at $63.44. Nearly 0.54 million shares were traded by the close, higher than its average daily volume of 0.41 million shares.AnaptysBio, Inc. (ANAB) Analyst Opinion
AnaptysBio, Inc. has a consensus buy rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 3.18% of shares outstanding. The stock spiked 82.4% last month and is up 273.18 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover ANAB having a buy-equivalent rating. Analysts have placed a $77.67 price target on AnaptysBio, Inc., suggesting a 22.43% gain from recent close. It’s currently trading about -14.27% below its 52-week high.
This stock (ANAB) is ahead of its 52-week low with 318.19%. Its last month’s stock price volatility remained 5.76% which for the week stands at 5.78%. The share price has moved forward from its 20 days moving average, trading at a distance of 40.87% and stays 87.45% away from its 50 days moving average. Over the last five days, shares have faced -9.29% losses and now is up 134.41% since hitting its 200-day moving average of $28.59. AnaptysBio, Inc. (ANAB) has made its way to a 12-month decline of 0%.
Turning to Kindred Healthcare, Inc. (NYSE:KND), its shares were trading at $6.35 a gain of $0.2, on the trading floor. The stock, after opening at $6.2, touched a high of $6.5 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3.5. Kindred Healthcare, Inc. has 0 buy ratings, 4 holds and 1 sells even after the stock tumbled -46.64% from its high of $11.9 to a $566.42 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 3.5 to 3.5 during a month. Analysts set a 12-month price target of $7.5 a share. The target implies a 18.11% spike from where the shares are currently trading. Also, the current price highlights a discount of 41.73% to analysts’ high consensus price target.Kindred Healthcare, Inc. (NYSE:KND) Intraday Trading
The counter witnessed a trading volume of 1.21 million shares versus an average volume of 1.31 million shares during last trading session. Its last month’s stock price volatility remained 4.39% which for the week approaches 5.5%. The lowest price the stock reached in the last trading day was $6.1 and compares with the $5.5 52-week low. The stock recovered 15.45% since its low point and has performed -19.11% year-to-date.